急性呼吸窘迫综合征患者床旁垂直化的生理效应与安全性
这项前瞻性先导性生理学研究在法国Clermont-Ferrand大学医院两个ICU纳入30例早期ARDS患者,从30°半坐位(基线)开始,每30分钟逐步垂直化至0°、30°、60°和90°,再回到基线。主要终点为垂直化过程中跨肺驱动压的变化。跨肺驱动压从基线中位数9(IQR 5-11)cmH2O轻度升至90°的10(IQR 7-14)cmH2O(混合模型位置总体效应P<10^-2)。垂直化使呼气末肺容积增加,同时肺泡应变降低、动脉氧合改善;但垂直化伴随心输出量和每搏量下降、去甲肾上腺素剂量和血清乳酸升高,2例患者因此中断操作。作者认为垂直化至90°在ARDS患者中可行,至30°可改善EELV和氧合,但超过30°有过度膨胀和血流动力学不稳定风险,需根据临床情况个体化调整床角度。
要点
- 早期ARDS患者从30°半坐位垂直化至30°可增加呼气末肺容积、降低肺泡应变并改善动脉氧合。
- 跨肺驱动压从基线中位数9(IQR 5-11)cmH2O轻度升至90°的10(IQR 7-14)cmH2O,混合模型位置总体效应P<10^-2。
- 垂直化伴随心输出量和每搏量下降、去甲肾上腺素剂量和血清乳酸升高,2例患者因此中断操作。
- 垂直化至90°在ARDS患者中可行,但超过30°有过度膨胀和血流动力学不稳定风险,作者建议根据临床情况个体化调整床角度。
- 研究期间未发生跌倒或设备意外移除等其他不良事件。
适用人群与场景
- 法国Clermont-Ferrand大学医院两个ICU的早期ARDS患者,共30例。
处置流程与药物剂量
- 从30°半坐位(基线)开始,每30分钟逐步垂直化至0°、30°、60°和90°,然后回到基线位置。
- 监测潮气量、呼气末正压(PEEP)、食管压和肺动脉导管数据。
红旗征与不能漏的情况
- 垂直化过程中出现心输出量和每搏量下降、去甲肾上腺素剂量和血清乳酸升高,2例患者因此中断操作。
研究设计与关键结果
- 前瞻性先导性生理学研究,纳入30例早期ARDS患者,在法国Clermont-Ferrand大学医院两个ICU进行,研究时间为2020年5月至2021年1月。
- 主要终点跨肺驱动压从基线中位数9(IQR 5-11)cmH2O轻度升至90°的10(IQR 7-14)cmH2O,混合模型位置总体效应P<10^-2。
- 垂直化使呼气末肺容积增加,同时肺泡应变降低、动脉氧合改善。
- 垂直化伴随心输出量和每搏量下降、去甲肾上腺素剂量和血清乳酸升高,2例患者因此中断操作。
- 未发生跌倒或设备意外移除等其他不良事件。
证据类型、等级与局限
- 前瞻性先导性生理学研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为垂直化至90°在ARDS患者中可行,至30°可改善EELV和氧合,可能由于肺泡复张和血流重分布。
- 作者认为超过30°有过度膨胀和血流动力学不稳定风险,需根据临床情况个体化调整床角度。
指南或共识出处
- 研究注册于ClinicalTrials.gov,注册号NCT04371016,注册日期2020年4月24日。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Trunk inclination in patients with Acute Respiratory Distress Syndrome (ARDS) in the supine position has gained scientific interest due to its effects on respiratory physiology, including mechanics, oxygenation, ventilation distribution, and efficiency. Changing from flat supine to semi-recumbent increases driving pressure due to decreased respiratory system compliance. Positional adjustments also deteriorate ventilatory efficiency for CO2 removal, particularly in COVID-19-associated ARDS (C-ARDS), indicating likely lung parenchyma overdistension. Tilting the trunk reduces chest wall compliance and, to a lesser extent, lung compliance and transpulmonary driving pressure, with significant hemodynamic and gas exchange implications.
METHODS: A prospective, pilot physiological study was conducted on early ARDS patients in two ICUs at CHU Clermont-Ferrand, France. The protocol involved 30-min step gradual verticalization from a 30° semi-seated position (baseline) to different levels of inclination (0°, 30°, 60°, and 90°), before returning to the baseline position. Measurements included tidal volume, positive end-expiratory pressure (PEEP), esophageal pressures, and pulmonary artery catheter data. The primary endpoint was the variation in transpulmonary driving pressure through the verticalization procedure.
RESULTS: From May 2020 through January 2021, 30 patients were included. Transpulmonary driving pressure increased slightly from baseline (median and interquartile range [IQR], 9 [5-11] cmH2O) to the 90° position (10 [7-14] cmH2O; P < 10-2 for the overall effect of position in mixed model). End-expiratory lung volume increased with verticalization, in parallel to decreases in alveolar strain and increased arterial oxygenation. Verticalization was associated with decreased cardiac output and stroke volume, and increased norepinephrine doses and serum lactate levels, prompting interruption of the procedure in two patients. There were no other adverse events such as falls or equipment accidental removals.
CONCLUSIONS: Verticalization to 90° is feasible in ARDS patients, improving EELV and oxygenation up to 30°, likely due to alveolar recruitment and blood flow redistribution. However, there is a risk of overdistension and hemodynamic instability beyond 30°, necessitating individualized bed angles based on clinical situations. Trial registration ClinicalTrials.gov registration number NCT04371016 , April 24, 2020.
参考来源
- Bouchant L, Godet T, Arpajou G, et al. Physiological effects and safety of bed verticalization in patients with acute respiratory distress syndrome. Crit Care. 2024. PMID: 39103928. doi:10.1186/s13054-024-05013-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。